Serina Therapeutics, Inc. Conversion of Stock, Shares Issued
Serina Therapeutics, Inc. (SER) reported Conversion of Stock, Shares Issued of 0.977 shares for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-12.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:ConversionOfStockSharesIssued1 · last filed 2024-11-12
- Serina Therapeutics, Inc. conversion of stock, shares issued for the quarter ending 2024-09-30 was 0.00 shares.
- Serina Therapeutics, Inc. conversion of stock, shares issued for the quarter ending 2024-06-30 was 0.00 shares.
- Serina Therapeutics, Inc. conversion of stock, shares issued for the quarter ending 2024-03-31 was 0.98 shares.
| Period end | Conversion of Stock, Shares Issued 3 month | Conversion of Stock, Shares Issued 6 month | Conversion of Stock, Shares Issued 9 month |
|---|---|---|---|
| 2024-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | 0.00 shares derived: sum of 2 quarters · filed 2024-11-12 | 0.98 shares 10-Q · filed 2024-11-12 |
| 2024-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | 0.98 shares 10-Q · filed 2024-08-09 | |
| 2024-03-31 | 0.98 shares 10-Q · filed 2024-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B |